Advanced search
Publication Cover
Cancer Investigation Volume 28, 2010 - Issue 8
Submit an article Journal homepage
83
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction

Imtiaz MalikLoma Linda Oncology Medical Group Inc, Claremont, CA, USA, Loma Linda Cancer Institute, Loma Linda, CA, USACorrespondence[email protected]
,
Pedro BernalLoma Linda Oncology Medical Group Inc, Claremont, CA, USA, Loma Linda Cancer Institute, Loma Linda, CA, USA
&
Janet ByrdLoma Linda Oncology Medical Group Inc, Claremont, CA, USA, Loma Linda Cancer Institute, Loma Linda, CA, USA
Pages 833-838 | Published online: 14 Sep 2010

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Thierry Delaunoit. (2011) Latest developments and emerging treatment options in the management of stomach cancer. Cancer Management and Research 3, pages 257-266.
Read now
Yung-Jue Bang. (2011) Capecitabine in gastric cancer. Expert Review of Anticancer Therapy 11:12, pages 1791-1806.
Read now

Articles from other publishers (3)

Gerardo Rosati, Chiara Alessandra Cella, Luigi Cavanna, Carla Codecà, Michele Prisciandaro, Stefania Mosconi, Giovanna Luchena, Nicola Silvestris, Ilaria Bernardini, Rossana Casaretti, Federica Zoratto, Domenico Amoroso, Andrea Ciarlo, Sandro Barni, Stefano Cascinu, Cristina Davite, Alessandro Di Sanzo, Alessia Casolaro, Domenico Bilancia & Roberto Labianca. (2022) A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial. Gastric Cancer 25:4, pages 783-793.
Crossref
Maarten J. Deenen, Didier Meulendijks, Henk Boot, Marie-Cecile J. C. Legdeur, Jos H. Beijnen, Jan H. M. Schellens & Annemieke Cats. (2015) Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction. Cancer Chemotherapy and Pharmacology 76:6, pages 1285-1295.
Crossref
Sergio Frustaci, Angela Buonadonna, Elisa Turchet, Giuseppe Corona, Gianna Tabaro, GianMaria Miolo, Elena Torrisi, Giovanni Lo Re, Salvatore Tumolo & Giuseppe Toffoli. (2012) Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients. International Journal of Clinical Oncology 18:3, pages 510-516.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.